DENTIPATCH Drug Patent Profile

Which patents cover Dentipatch, and when can generic versions of Dentipatch launch?

Dentipatch is a drug marketed by Noven and is included in one NDA.

The generic ingredient in DENTIPATCH is lidocaine. There are twenty-nine drug master file entries for this compound. Forty-four suppliers are listed for this compound. Additional details are available on the lidocaine profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Dentipatch

A generic version of DENTIPATCH was approved as lidocaine by ACTAVIS LABS UT INC on August 23^rd, 2012.

Summary for DENTIPATCH

US Patents:	0
Applicants:	1
NDAs:	1
Raw Ingredient (Bulk) Api Vendors:	131
Patent Applications:	5,238
DailyMed Link:	DENTIPATCH at DailyMed

US Patents and Regulatory Information for DENTIPATCH

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Noven	DENTIPATCH	lidocaine	FILM, EXTENDED RELEASE;BUCCAL	020575-001	May 21, 1996		DISCN	No	No
Noven	DENTIPATCH	lidocaine	PATCH;TOPICAL	020575-002	May 21, 1996		DISCN	No	No

Expired US Patents for DENTIPATCH

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Noven	DENTIPATCH	lidocaine	PATCH;TOPICAL	020575-002	May 21, 1996	5,332,576
Noven	DENTIPATCH	lidocaine	FILM, EXTENDED RELEASE;BUCCAL	020575-001	May 21, 1996	5,234,957
Noven	DENTIPATCH	lidocaine	PATCH;TOPICAL	020575-002	May 21, 1996	5,446,070
Noven	DENTIPATCH	lidocaine	PATCH;TOPICAL	020575-002	May 21, 1996	5,234,957
Noven	DENTIPATCH	lidocaine	FILM, EXTENDED RELEASE;BUCCAL	020575-001	May 21, 1996	5,446,070
Noven	DENTIPATCH	lidocaine	FILM, EXTENDED RELEASE;BUCCAL	020575-001	May 21, 1996	5,332,576

International Patents for DENTIPATCH

See the table below for patents covering DENTIPATCH around the world.

Country	Patent Number	Title	Estimated Expiration
Hong Kong	1006155
Norway	962833
Australia	3284789
European Patent Office	0728477
Denmark	0379044
Japan	2724043

DENTIPATCH Market Analysis and Financial Projection Experimental

Market Dynamics and Financial Trajectory for Dentipatch: A Comprehensive Analysis

Introduction to Dentipatch

Dentipatch, often associated with pain management solutions like lidocaine and benzocaine, is a significant player in the transdermal patch market. These patches are designed to deliver medication through the skin, providing effective pain relief for various dental and medical procedures.

Global Market Size and Growth

The market for transdermal patches, including those containing lidocaine and benzocaine, is experiencing robust growth. Here are some key statistics:

• The global lidocaine market, which includes transdermal patches, is projected to reach USD 3.5 billion by 2032, growing at a CAGR of 8.4% from 2024 to 2032[3].
• The lidocaine transdermal patch market specifically is expected to reach USD 7,934.75 million by 2030, growing at a CAGR of 1.9% from 2024 to 2030[4].

Key Drivers of Market Growth

Increasing Demand for Minimally Invasive Procedures

The rise in minimally invasive surgical procedures, particularly in North America, is a significant driver for the demand of lidocaine and similar transdermal patches. These procedures often require local anesthesia, which lidocaine patches can effectively provide[3].

Prevalence of Dental and Periodontal Diseases

The increasing prevalence of dental and periodontal diseases has led to a higher demand for lidocaine in dental procedures. This trend is further exacerbated by growing awareness and preference for preventive healthcare practices[3].

Cosmetic and Pain Management Applications

Lidocaine's use in cosmetic procedures and pain management for conditions such as chronic pain, minor cuts, and skin scrapes is also driving market growth. Innovations in formulation technologies, such as patches and gels, have enhanced its efficacy and patient compliance[3].

Rising Healthcare Spending and Aging Population

The global healthcare spending is increasing, particularly in regions with aging populations and a high prevalence of chronic diseases. This trend supports the growth of the transdermal patch market, including Dentipatch[4].

Regional Market Dynamics

North America

North America is the largest market shareholder for lidocaine transdermal patches, expected to grow at a CAGR of 8.7% during the forecast period. This region's high demand for minimally invasive procedures and well-developed healthcare infrastructure contribute to its dominant position[3].

Asia-Pacific

The Asia-Pacific region is anticipated to witness notable growth due to increasing investments in the development of novel drug delivery systems, a rising geriatric population, and a surge in the personalization of pain management. These factors are expected to drive the growth of the Dentipatch market in this region[1].

Competitive Landscape

Key Market Players

The market for transdermal patches, including Dentipatch, is competitive with several key players. Companies such as Hisamitsu Pharmaceutical Co., Inc., Amneal Pharmaceuticals LLC, Johnson & Johnson, and Viatris Inc. hold significant market positions due to their strong geographical foothold and innovative product offerings[1].

Market Positioning

These key players are focusing on developing novel formulations and expanding their distribution networks. For instance, Scilex Holding Company reported significant financial growth due to its focus on non-opioid pain management products, including transdermal patches[3].

Technological Advancements

Innovations in Formulation Technologies

Advancements in drug delivery technologies, such as patches and gels, are enhancing the efficacy and patient compliance of lidocaine and similar medications. These innovations are expected to continue driving market growth in the future[3].

Bioadhesive Patches

Bioadhesive patches, as studied in the context of benzocaine and lidocaine, have shown promising results in reducing pain associated with minor oral procedures. These patches are prepared with constituents like hydroxypropylmethylcellulose (HPMC) and dimethyl sulfoxide (DMSO), which aid in the dissolution and delivery of the anesthetic agent[5].

Challenges and Opportunities

Regulatory Approvals and Competition

While the market is growing, it faces challenges such as regulatory approvals and competition from other pain management products. However, the trend towards innovative formulations and the increasing demand for non-opioid pain management solutions present significant opportunities for growth[3].

Supportive Regulatory Environment

A supportive regulatory environment can drive innovation and market entry, which in turn can spur market growth. Laws and guidelines controlling the development, approval, and marketing of transdermal drug delivery systems are crucial for the expansion of the Dentipatch market[4].

Efficacy and Clinical Studies

Comparison of Benzocaine and Lidocaine Patches

Studies have compared the efficacy of benzocaine and lidocaine bioadhesive patches in reducing pain associated with various minor oral procedures. Benzocaine patches have shown statistically significant reductions in pain rating scores compared to lidocaine patches, particularly in procedures like needle insertions and extractions[5].

Clinical Implications

The successful treatment of patients, especially in pediatric dentistry, depends greatly on providing painless anesthesia. Topical anesthesia using bioadhesive patches like Dentipatch can be a breakthrough in this field, enhancing patient compliance and reducing fear associated with dental procedures[5].

Financial Trajectory

Market Value and Growth Rate

The financial trajectory of the Dentipatch market is promising, with the global lidocaine market projected to reach USD 3.5 billion by 2032 and the lidocaine transdermal patch market expected to reach USD 7,934.75 million by 2030[3][4].

Revenue Growth of Key Players

Companies like Scilex Holding Company have reported significant revenue growth due to their focus on non-opioid pain management products. For example, Scilex Holding Company reported a 48% to 85% increase in ZTlido net sales and a 54% to 89% increase in total product net sales for July 2024 compared to the same period last year[3].

Key Takeaways

• The global market for transdermal patches, including Dentipatch, is driven by increasing demand for minimally invasive procedures, prevalence of dental and periodontal diseases, and growing applications in cosmetic and pain management.
• North America is the largest market shareholder, with a high CAGR during the forecast period.
• Innovations in formulation technologies and rising healthcare spending are key drivers of market growth.
• Companies focusing on non-opioid pain management products are experiencing significant financial growth.
• Regulatory support and expanding distribution networks are crucial for market expansion.

FAQs

1. What is the projected global market size for lidocaine transdermal patches by 2030?

The global lidocaine transdermal patch market is projected to reach USD 7,934.75 million by 2030[4].

2. Which region is the largest market shareholder for lidocaine transdermal patches?

North America is the largest market shareholder for lidocaine transdermal patches, expected to grow at a CAGR of 8.7% during the forecast period[3].

3. What are the primary drivers of the lidocaine transdermal patch market growth?

The primary drivers include the increasing demand for minimally invasive procedures, prevalence of dental and periodontal diseases, and growing applications in cosmetic and pain management[3].

4. How are key players performing in the lidocaine transdermal patch market?

Companies like Scilex Holding Company are reporting significant revenue growth due to their focus on non-opioid pain management products, including transdermal patches[3].

5. What are the key challenges facing the lidocaine transdermal patch market?

The market faces challenges such as regulatory approvals, competition from other pain management products, and market dynamics that can impact long-term performance[3].

Sources

1. Allied Market Research: Pain Patch Market Statistics, Growth Drivers | Forecast - 2031.
2. SSRN: Financial Incisors: Cutting Through the Effects of Private Equity on Dentistry Market Dynamics and Care Delivery.
3. Drug Patent Watch: Market Dynamics and Financial Trajectory for Lidocaine.
4. Verified Market Research: Lidocaine Transdermal Patch Market Size, Forecast.
5. Indian Journal of Dental Research: Efficacy of Benzocaine and Lidocaine Bioadhesive Patches in Reducing Pain Associated with Various Minor Oral Procedures.